DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC

EIN: 990991065 501(c)(3) Medical Research

NEW YORK, NY

Total Revenue
$629,357
Total Expenses
$97,425
Total Assets
$538,884
Net Assets
$538,884
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2024
Legal Domicile
NY
Principal Officer
VINCENT RELLA
Phone
2125883264
Tax Period
2024-04-30 to 2024-12-31

DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC, founded in 2024, is a small nonprofit in the Medical Research sector that reported $629K in total revenue in fiscal year 2024. The organization ran a surplus of $532K, a strong 85% operating margin.

Mission

DEDICATED TO ADVANCING GLIOBLASTOMA RESEARCH AND THERAPIES.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $615,339
Program Service Revenue $0
Investment Income $14,018
Other Revenue $0
TOTAL REVENUE $629,357

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $97,425
Other Expenses $97,425
TOTAL EXPENSES $97,425

Year-over-Year Comparison

2024 2023 Change
Revenue $629,357 N/A N/A
Expenses $97,425 N/A N/A
Net Income $531,932 N/A N/A
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
3
Independent Members
3
Employees
N/A
Volunteers
N/A

Governance Policies

✓ Conflict of Interest Policy
✓ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
⚠ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
2
$0
Total Directors
3
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
MORRIS OFFIT DIRECTOR 2.00
Director
$0 $0 $0
NED OFFIT PRESIDENT 2.00
Officer Director
$0 $0 $0
VINCENT RELLA SECRETARY/TREASURER 2.00
Officer Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $629,357 $97,425 $538,884 $531,932
Explore More Nonprofits
→Top 100 Nonprofits in New York →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare DANIEL W OFFIT FUND TO FIGHT GLIOBLASTOMA INC with other nonprofits in New York and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.